Table 3.
Recommendation Group* | Total | Received Testing (% Total) | Gonorrhea Positive† | Chlamydia Positive† | |
---|---|---|---|---|---|
Female N=466 | 1 | 234 (50.2%) | 131 (56.0%) | 9 (6.9%) | 25 (19.1%) |
2 | 72 (15.4%) | 20 (27.8%) | 1 (5.0%) | 4 (20.0%) | |
3 | 155 (33.2%) | 14 (9.0%) | 0 | 2 (14.3%) | |
4 | 5 (1.1%) | 1 (20.0%) | 0 | 0 | |
Male N=334 | 1 | 185 (55.4%) | 90 (48.6%) | 3 (3.3%) | 10 (11%) |
2 | 16 (4.8%) | 3 (18.8%) | 0 | 0 | |
3 | 124 (37.1%) | 5 (4.0%) | 0 | 0 | |
4 | 9 (2.7%) | 1 (11.1%) | 0 | 0 |
1=Patients should be offered testing, based on CDC criteria or endorsed symptoms; 2= Patient does not need testing but sexual history indicated elevated infection risk; 3= Patient does not need testing or have elevated infection risk; 4= Patient left too many answers blank to provide a recommendation.
1 man and 6 women tested positive for both chlamydia and gonorrhea
ACASI – Audio-enhanced Computer-Assisted Self-Interview; CDC – Centers for Disease Control and Prevention